Industry experts highlight a looming 'talent singularity' in biomanufacturing by 2028, driven by a shortage of skilled workers aligned with evolving technological demands. Jason Beckwith of Merrill underscores the misalignment between current university curricula and biopharma's needs, calling for cross-industry recruitment, upskilling, and retention strategies. Collaborations with institutes like NIBRT and UCL aim to map critical skills for future workforce readiness. Without intervention, demand for highly trained biomanufacturing personnel could exceed supply, impacting productivity and innovation.